Literature DB >> 21497835

Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery.

Andrea Székely1, Jack Levin, Yinghui Miao, Iulia C Tudor, Alain Vuylsteke, Peter Ofner, Dennis T Mangano.   

Abstract

OBJECTIVE: The roles of perioperative hyperglycemia and diabetes in the risk stratification of patients undergoing coronary artery bypass graft surgery are unclear. The aim of this study is to explore the influence of perioperative hyperglycemia on postoperative mortality.
METHOD: A prospective, observational study of 5050 patients undergoing cardiopulmonary bypass for coronary artery bypass graft surgery at 70 international centers was conducted, with 7500 measured variables per patient and outcomes adjudicated centrally. Postoperative blood glucose levels measured from the day of surgery to postoperative day 3 were available for 4799 patients. Multivariable logistic regression was used to determine the association of hyperglycemia with hospital mortality.
RESULTS: A total of 164 patients died during hospitalization (3.2%). Mortality was significantly higher in the diabetic population compared with the nondiabetic population (4.2% vs 2.9%; P = .02). In nondiabetic patients, maximum postoperative blood glucose between 250 and 300 mg/dL (adjusted odds ratio, 2.56; 95% confidence interval, 1.18-5.57; P = .02) and maximum blood glucose of 300 mg/dL or greater (adjusted odds ratio, 2.74; 95% confidence interval, 1.22-6.16; P = .01), compared with maximum blood glucose less than 200 mg/dL, and postoperative insulin treatment (adjusted odds ratio, 2.04; 95% confidence interval, 1.12-3.70), were independent risk factors for an increased risk of in-hospital mortality. In diabetic patients, hyperglycemia was not associated with a higher mortality risk.
CONCLUSIONS: Postoperative hyperglycemia is associated with increased in-hospital mortality in nondiabetic patients after coronary artery bypass graft surgery. In diabetic patients, hyperglycemia was not associated with mortality.
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497835     DOI: 10.1016/j.jtcvs.2011.03.009

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  18 in total

Review 1.  Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients.

Authors:  Rodolfo J Galindo; Maya Fayfman; Guillermo E Umpierrez
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

2.  Stress hyperglycemia in general surgery: Why should we care?

Authors:  Georgia Davis; Maya Fayfman; David Reyes-Umpierrez; Shahzeena Hafeez; Francisco J Pasquel; Priyathama Vellanki; J Sonya Haw; Limin Peng; Sol Jacobs; Guillermo E Umpierrez
Journal:  J Diabetes Complications       Date:  2017-11-29       Impact factor: 2.852

3.  Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study.

Authors:  Brian C Gulack; Katherine A Kirkwood; Wei Shi; Peter K Smith; John H Alexander; Sandra G Burks; Annetine C Gelijns; Vinod H Thourani; Daniel Bell; Ann Greenberg; Seth D Goldfarb; Mary Lou Mayer; Michael E Bowdish
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-06       Impact factor: 5.209

4.  A Prospective Multi-Institutional Cohort Study of Mediastinal Infections After Cardiac Operations.

Authors:  Louis P Perrault; Katherine A Kirkwood; Helena L Chang; John C Mullen; Brian C Gulack; Michael Argenziano; Annetine C Gelijns; Ravi K Ghanta; Bryan A Whitson; Deborah L Williams; Nancy M Sledz-Joyce; Brian Lima; Giampaolo Greco; Nishit Fumakia; Eric A Rose; John D Puskas; Eugene H Blackstone; Richard D Weisel; Michael E Bowdish
Journal:  Ann Thorac Surg       Date:  2017-12-07       Impact factor: 4.330

5.  A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis.

Authors:  Katherine A Kirkwood; Brian C Gulack; Alexander Iribarne; Michael E Bowdish; Giampaolo Greco; Mary Lou Mayer; Karen O'Sullivan; Annetine C Gelijns; Nishit Fumakia; Ravi K Ghanta; Jesse M Raiten; Anuradha Lala; Joseph S Ladowski; Eugene H Blackstone; Michael K Parides; Alan J Moskowitz; Keith A Horvath
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-28       Impact factor: 5.209

6.  Glycemic Control in Coronary Revascularization.

Authors:  Francisco Ujueta; Ephraim N Weiss; Steven P Sedlis; Binita Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

7.  Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis.

Authors:  Yi Yun Lin; Bin He; Jian Chen; Zhi Nong Wang
Journal:  Crit Care       Date:  2012-09-27       Impact factor: 9.097

Review 8.  Medanta insulin protocols in patients undergoing cardiac surgery.

Authors:  Beena Bansal; Ambrish Mithal; Pravin Carvalho; Yatin Mehta; Naresh Trehan
Journal:  Indian J Endocrinol Metab       Date:  2014-07

Review 9.  Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis.

Authors:  Xiaoling Li; Nina C Weber; Danny M Cohn; Markus W Hollmann; J Hans DeVries; Jeroen Hermanides; Benedikt Preckel
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

10.  Glycemic Control during Coronary Artery Bypass Graft Surgery.

Authors:  Harold L Lazar
Journal:  ISRN Cardiol       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.